July 30, 2017

Natural product therapy for body weight control, energy homeostasis and TIIDM: A therapeutic mix encompassing Chlorogenic acid and Monascin, isolated from Green coffee and Edible fungi of the Monascus species, respectively, decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 31/July/2017, 12.48 pm

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
July 28, 2017

Natural product-derived therapy for glucose homeostasis and TIIDM: β-Cryptoxanthin, isolated from sweet peppers, increases Barr2 expression, augments the functional activity of CAMKII, increases insulin secretion, promotes glucose homeostasis, prevents progression to TIIDM and ameliorates obesity-associated metabolic deficits via down regulation of its target gene, 28/July/2017, 10.12 pm

Introduction: What they say A study from the Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland […]
July 28, 2017

Natural product therapy for glucose homeostasis and TIIDM: Artemether, a derivative of Artemisinin isolated from Artemesia Annua L,   increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 28/July/2017, 10.00 pm

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, […]
July 28, 2017

Molecular-therapy for Regenerating the lost pancreatic β-cells in Diabetic patients:  Beraprost Sodium increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene Lin28, 28/July/2017, 9.52 pm

Introduction: What they say:   A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis […]